Mcp and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Mcp (pectin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Esomeprazole Magnesium, and have High blood pressure.

The phase IV clinical study analyzes which people have Hyperventilation when taking Mcp. It is created by eHealthMe based on reports of 2,073 people who have side effects when taking Mcp from the FDA, and is updated regularly.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

What is Hyperventilation?

Hyperventilation is found to be associated with 871 drugs and 1,429 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Oct, 03, 2025

2,073 people reported to have side effects when taking Mcp.
Among them, 17 people (0.82%) have Hyperventilation.

Among these 17 people:

How long have people been on Mcp when they have Hyperventilation? *

What is the gender of people who have Hyperventilation when taking Mcp? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Hyperventilation when taking Mcp? *

What are other drugs people take besides Mcp? *

Victoza: 9 people, 52.94%
Valsartan: 9 people, 52.94%
Torsemide: 9 people, 52.94%
Telmisartan: 9 people, 52.94%
Symbicort: 9 people, 52.94%
Metformin Hydrochloride: 9 people, 52.94%
Lyrica: 9 people, 52.94%
Jardiance: 9 people, 52.94%
Ibuprofen: 9 people, 52.94%
Esomeprazole Magnesium: 9 people, 52.94%

What are other side effects people have besides Hyperventilation? *

C-Reactive Protein Increased: 15 people, 88.24%
Depression: 15 people, 88.24%
Pneumonia: 10 people, 58.82%
Diarrhea: 10 people, 58.82%
Weakness: 9 people, 52.94%
Electrocardiogram St Segment Depression: 9 people, 52.94%
Heart Disease: 9 people, 52.94%
Urination - Excessive At Night: 9 people, 52.94%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 9 people, 52.94%
General Physical Health Deterioration (weak health status): 9 people, 52.94%

What are the existing conditions these people have? *

High Blood Pressure: 15 people, 88.24%
Type 2 Diabetes: 9 people, 52.94%
Depression: 7 people, 41.18%
Nausea (feeling of having an urge to vomit): 6 people, 35.29%
Hepatic Pain (pain in liver): 6 people, 35.29%
Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 6 people, 35.29%
Diarrhea: 6 people, 35.29%
Diabetes: 6 people, 35.29%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 6 people, 35.29%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Mcp and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mcp:

Mcp (2,077 reports)

Browse all side effects of Mcp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (871 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,429 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pectin (the active ingredients of Mcp) and Mcp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.